Cargando…

Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs

The catastrophic global effects of the SARS-CoV-2 pandemic highlight the need to develop novel therapeutics strategies to prevent and treat viral infections of the respiratory tract. To enable this work, we need scalable, affordable, and physiologically relevant models of the human lung, the primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tong, Rabi, Seyed A., Michaud, William A., Becerra, David, Gilpin, Sarah E., Mino-Kenudson, Mari, Ott, Harald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999341/ https://www.ncbi.nlm.nih.gov/pubmed/35533440 http://dx.doi.org/10.1016/j.biomaterials.2022.121509

Ejemplares similares

Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases
por: Assylbekova, Akmaral, et al.
Publicado: (2022)

Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2
por: Escalante, Diego E., et al.
Publicado: (2021)

Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
por: Bittmann, Stefan, et al.
Publicado: (2020)

Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat
por: Sun, Gaohui, et al.
Publicado: (2021)

Camostat mesilate therapy for COVID-19
por: Uno, Yoshiharu
Publicado: (2020)

Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2
por: Zhu, Haixia, et al.
Publicado: (2020)

Inhibition of Listeria Monocytogenes HtrA Protease with Camostat, Gabexate and Nafamostat Mesylates and the Binding Mode of the Inhibitors
por: C, Amrutha M, et al.
Publicado: (2023)

Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat
por: Hempel, Tim, et al.
Publicado: (2020)

Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
por: Mino-Kenudson, Mari
Publicado: (2016)

Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective
por: Mino-Kenudson, Mari
Publicado: (2020)

The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells
por: Yamaya, Mutsuo, et al.
Publicado: (2015)

Acute eosinophilic pneumonia caused by camostat mesilate: The first case report
por: Ota, Shinichiro, et al.
Publicado: (2016)

Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
por: Sakr, Yasser, et al.
Publicado: (2021)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
por: Hoffmann, Markus, et al.
Publicado: (2020)

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
por: Hoffmann, Markus, et al.
Publicado: (2021)

A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats
por: Iwata, Yasunobu, et al.
Publicado: (2023)

Animal Models of Colitis-Associated Carcinogenesis
por: Kanneganti, Manasa, et al.
Publicado: (2011)

Infections of the Gastrointestinal Tract
por: Lauwers, Gregory, et al.
Publicado: (2010)

Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation
por: Hofmann-Winkler, Heike, et al.
Publicado: (2020)

SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
por: Becerra‐Flores, Manuel, et al.
Publicado: (2020)

Infections of the Gastrointestinal Tract
por: Lauwers, Gregory Y., et al.
Publicado: (2018)

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
por: Brustolin, Marco, et al.
Publicado: (2021)

Retrovirus Entry by Endocytosis and Cathepsin Proteases
por: Kubo, Yoshinao, et al.
Publicado: (2012)

Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations
por: Ramakrishnan, Jaganathan, et al.
Publicado: (2021)

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
por: Ozono, Seiya, et al.
Publicado: (2021)

Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis
por: Bello, Elisa, et al.
Publicado: (2019)

Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage
por: Huang, Sheng-Yu, et al.
Publicado: (2021)

Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19
por: Sharma, Tanuj, et al.
Publicado: (2022)

Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study
por: Kim, Gwanyoung, et al.
Publicado: (2023)

A Role of Three-Dimensional (3D)-Reconstruction in the Classification of Lung Adenocarcinoma
por: Onozato, Maristela L., et al.
Publicado: (2012)

Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19
por: Stone, James R., et al.
Publicado: (2020)

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
por: Gobeil, Sophie M.-C., et al.
Publicado: (2021)

Protease inhibitors targeting coronavirus and filovirus entry
por: Zhou, Yanchen, et al.
Publicado: (2015)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters
por: Stauft, Charles B., et al.
Publicado: (2021)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions
por: Weiss, Johanna, et al.
Publicado: (2021)

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021)

The high mutation rate at the D614G hotspot-furin cleavage site region increases the priming efficiency of the Spike protein by furin protease: analysis of Indonesian SARS-CoV-2 G614 variants obtained during the early COVID-19 pandemic
por: Gazali, Faris Muhammad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_afkv51jbmsk8q1ddhi3rb9rbdi